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Mass spectrometry-based proteomics has become the tool of choice
for identifying and quantifying the proteome of an organism. Though
recent years have seen a tremendous improvement in instrument per-
formance and the computational tools used, significant challenges
remain, and there are many opportunities for statisticians to make
important contributions. In the most widely used “bottom-up” ap-
proach to proteomics, complex mixtures of proteins are first sub-
jected to enzymatic cleavage, the resulting peptide products are sep-
arated based on chemical or physical properties and analyzed using
a mass spectrometer. The two fundamental challenges in the analy-
sis of bottom-up MS-based proteomics are as follows: (1) Identifying
the proteins that are present in a sample, and (2) Quantifying the
abundance levels of the identified proteins. Both of these challenges
require knowledge of the biological and technological context that
gives rise to observed data, as well as the application of sound statis-
tical principles for estimation and inference. We present an overview
of bottom-up proteomics and outline the key statistical issues that
arise in protein identification and quantification.
1. Introduction. The 1990s marked the emergence of genome sequenc-
ing and deoxyribonucleic acid (DNA) microarray technologies, giving rise to
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the “-omics” era of research. Proteomics is the logical continuation of the
widely-used transcriptional profiling methodology [Wilkins et al. (1996)].
Proteomics involves the study of multiprotein systems in an organism, the
complete protein complement of its genome, with the aim of understanding
distinct proteins and their roles as a part of a larger networked system. This
is a vital component of modern systems biology approaches, where the goal
is to characterize the system behavior rather than the behavior of a single
component. Measuring messenger ribonucleic acid (mRNA) levels as in DNA
microarrays alone does not necessarily tell us much about the levels of cor-
responding proteins in a cell and their regulatory behavior, since proteins
are subjected to many post-translational modifications and other modifi-
cations by environmental agents. Proteins are responsible for the structure,
energy production, communications, movements and division of all cells, and
are thus extremely important to a comprehensive understanding of systems
biology.
While genome-wide microarrays are ubiquitous, proteins do not share the
same hybridization properties of nucleic acids. In particular, interrogating
many proteins at the same time is difficult due to the need for having an
antibody developed for each protein, as well as the different binding con-
ditions optimal for the proteins to bind to their corresponding antibodies.
Protein microarrays are thus not widely used for whole proteome screen-
ing. Two-dimensional gel electrophoresis (2-DE) can be used in differential
expression studies by comparing staining patterns of different gels. Quanti-
tation of proteins using 2-DE has been limited due to the lack of robust and
reproducible methods for detecting, matching and quantifying spots as well
as some physical properties of the gels [Ong and Mann (2005)]. Although
efforts have been made to provide methods for spot detection and quantifi-
cation [Morris, Clark and Gutstein (2008)], 2-DE is not currently the most
widely-used technology for protein quantitation in complex mixtures. Mean-
while, mass spectrometry (MS) has proven effective for the characterization
of proteins and for the analysis of complex protein samples [Nesvizhskii,
Vitek and Aebersold (2007)]. Several MS methods for interrogating the pro-
teome have been developed: Surface Enhanced Laser Desorption Ionization
(SELDI) [Tang, Tornatore and Weinberger (2004)], Matrix Assisted Laser
Desorption Ionization (MALDI) [Karas et al. (1987)] coupled with time-of-
flight (TOF) or other instruments, and gas chromatography MS (GC-MS)
or liquid chromatography MS (LC-MS). SELDI and MALDI do not incor-
porate online separation during MS analysis, thus, separation of complex
mixtures needs to be performed beforehand. MALDI is widely used in tissue
imaging [Caprioli, Farmer and Gile (1997); Cornett et al. (2007); Stoeckli
et al. (2001)]. GS-MS or LC-MS allow for online separation of complex sam-
ples and thus are much more widely used in high-throughput quantitative
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Fig. 1. Overview of LC-MS-based proteomics. Proteins are extracted from biological sam-
ples, then digested and ionized prior to introduction to the mass spectrometer. Each MS
scan results in a mass spectrum, measuring m/z values and peak intensities. Based on
observed spectral information, database searching is typically employed to identify the pep-
tides most likely responsible for high-abundance peaks. Finally, peptide information is rolled
up to the protein level, and protein abundance is quantified using either peak intensities
or spectral counts.
Fig. 2. Sample preparation. Complex biological samples are first processed to extract
proteins. Proteins are typically fractionated to eliminate high-abundance proteins or other
proteins that are not of interest. The remaining proteins are then digested into peptides,
which are commonly introduced to a liquid chromatography column for separation. Upon
eluting from the LC column, peptides are ionized.
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Fig. 3. Mass spectrometry. The mass spectrometer consists of an ion source, responsible
for ionizing peptides, the mass analyzer and the detector, responsible for recording m/z
values and intensities, respectively, for each ion species. Each MS scan results in a mass
spectrum, and a single sample may be subjected to thousands of scans.
proteomics. Here we focus on the most widely-used “bottom-up” approach
to MS-based proteomics, LC-MS.
In LC-MS-based proteomics, complex mixtures of proteins are first sub-
jected to enzymatic cleavage, then the resulting peptide products are an-
alyzed using a mass spectrometer; this is in contrast to “top-down” pro-
teomics, which deals with intact proteins and is limited to simple protein
mixtures [Han, Aslanian and Yates (2008)]. A standard bottom-up exper-
iment has the following key steps (Figures 1–3): (a) extraction of proteins
from a sample, (b) fractionation to remove contaminants and proteins that
are not of interest, especially high abundance house-keeping proteins that are
not usually indicative of the disease being studied, (c) digestion of proteins
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Fig. 4. Data acquisition: ( a) Scan numbers and m/z values for an example raw LC-MS
data set. Each individual scan contains a single mass spectrum. (b) The mass spectrum
for scan 5338. ( c) A zoomed-in look at the scans 5275–5400 in m/z range 753–755.5. The
cluster of dots is indicative of a single LC-MS “feature.” (d) The isotopic distribution for
this feature in scan 5280. Peaks are separated by approximately 1/3, indicating a charge
state of +3. The monoisotopic mass is thus 753.36 × 3 = 2260.08 Da. ( e) The elution
profile at m/z 753.36.
into peptides, (d) post-digestion separations to obtain a more homogeneous
mixture of peptides, and (e) analysis by MS. The two fundamental challenges
in the analysis of MS-based proteomics data are then the identification of
the proteins present in a sample, and the quantification of the abundance
levels of those proteins. There are a host of informatics tasks associated with
each of these challenges (Figures 4–6).
The first step in protein identification is the identification of the con-
stituent peptides. This is carried out by comparing observed features to
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Fig. 5. Protein identification. Peptide and protein identification is most commonly ac-
complished by matching observed spectral measurements to theoretical or previously-ob-
served measurements in a database. In LC-MS/MS, measurements consist of fragmenta-
tion spectra, whereas mass and elution time alone are used in high-resolution LC-MS. Once
a best match is found, one of the following methods for assessing confidence in the match
is employed: decoy databases, empirical Bayes, or “expectation values.”
entries in a database of theoretical or previously identified peptides (Figure
5). In tandem mass spectrometry (denoted by MS/MS), a parent ion possi-
bly corresponding to a peptide is selected in MS1 for further fragmentation
in MS2. Resulting fragmentation spectra are compared to fragmentation
spectra in a database, using software like SEQUEST [Eng, McCormack and
Yates (1994)], Mascot [Perkins et al. (1999)] or X!Tandem Alternatively,
high-resolution MS instruments can be used to obtain extremely accurate
mass measurements, and these can be compared to mass measurements in a
database of peptides previously identified with high confidence via MS/MS
[Pasa-Tolic et al. (2004)] using the same software tools above. In either case,
a statistical assessment of the peptide identification confidence level is de-
sired. Protein identification can be carried out by rolling up peptide-level
identification confidence levels to the protein level, a process that is associ-
ated with a host of issues and complexities [Nesvizhskii et al. (2003)]. The
goal of the identification process is generally to identify as many proteins as
possible, while controlling the number of false identifications at a tolerable
level. There are a myriad of options for the exact identification method used,
including (i) the choice of a statistic for scoring the similarity between an
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Fig. 6. Protein quantitation. The left panel shows the proportion of missing values in
an example data set as a function of the mean of the observed intensities for each pep-
tide. There is a strong inverse relationship between these, suggesting that many missing
intensities have been censored. The right panel shows an example protein found to be dif-
ferentially expressed in a two-class human study. The protein had 6 peptides that were
identified, although two were filtered out due to too many missing values (peptides 1 and
2, as indicated by the vertical shaded lines). Estimated protein abundances and confidence
intervals are constructed from the peptide-level intensities by a censored likelihood model
[Karpievitch et al. (2009a)].
observed spectral pattern and a database entry [Craig and Beavis (2004);
Perkins et al. (1999)], and (ii) the choice of how to model the null distri-
bution of the similarity metric [Elias and Gygi (2007); Keller et al. (2002)].
Two other methods of protein identification exist: de novo and hybrids of
de novo and database matching. This is further explained in Section 5.
In quantitation experiments, protein abundances are inferred from the
identified peptides. One of the most common and simplest methods is to
count the number of times a peptide has been seen and accumulate those
counts for all the peptides seen for a given protein. This gives a value that is
proportional to the abundance of the protein, that is, a more abundant pro-
tein would be expected to have peptides that are observed more often [Liu,
Sadygov and Yates (2004); Zhang et al. (2009)]. A more accurate method for
quantifying the abundance of a peptide is to calculate the peak volume (or
area) across its elution profile using its extracted ion chromatogram. Protein
abundances are inferred from the corresponding peptide abundances (Figure
6). Peak capacity is a function of the number of ions detected for a particu-
lar peptide, and is related to peptide abundance [Old et al. (2005)]. Peptide
abundances can be computed with or without the use of stable isotope la-
bels [Gygi et al. (1999); Wang et al. (2003)]. In the case of isotopic labeled
experiments, usually a ratio of the peak capacities of the two isotopically la-
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beled components is reported. Regardless of the specific technology used to
quantify peptide abundances, statistical models are required to roll peptide-
level abundance estimates up to the protein level. Issues include widespread
missing data due to low-abundance peptides, misidentified peptides, under-
sampling of peaks for fragmentation in MS/MS, and degenerate peptides
that map to multiple proteins, among others. This is further explained in
Section 6.
The purpose of this paper is to provide an accessible overview of LC-MS-
based proteomics. Our template for this paper was a 2002 Biometrics paper
of similar focus in the DNA microarray setting [Nguyen et al. (2002)]. It
is our hope that this, like the 2002 paper for DNA microarrays, will serve
as an entry-point for more statisticians to join the exciting research that is
ongoing in the field of LC-MS-based proteomics.
2. Basic biological principles underlying proteomics. Proteins are the
major structural and functional units of any cell. Proteins consist of amino
acids arranged in a linear sequence, which is then folded to make a func-
tional protein. The sequence of amino acids in proteins is encoded by genes
stored in a DNA molecule. The transfer of information from genetic se-
quence to protein in eukaryotes proceeds by transcription and translation.
In transcription, single-stranded mRNA representations of a gene are con-
structed. The mRNA leaves the nucleus and is processed into protein by
the ribosome in the translation step. This information transfer, from DNA
to mRNA to protein, is essential for cell viability and function. In genomic
studies, microarray experiments measure gene expression levels by measur-
ing the transcribed mRNA abundance. Such measurements can show the
absence, under- or over-expression of genes under different conditions. How-
ever, protein levels do not always correspond to the mRNA levels due to a
variety of factors such as alternative splicing or post translational modifica-
tions (PTMs). Thus, proteomics serves an important role in a systems-level
understanding of biological systems.
A three-nucleotide sequence (codon) of mRNA encodes for one amino
acid in a protein. The genetic code is said to be degenerate, as more than
one codon can specify the same amino acid. In theory, mRNA could be
read in three different reading frames producing distinct proteins. In prac-
tice, however, most mRNAs are read in one reading frame due to start and
stop codon positions in the sequence. The raw polypeptide chain (a chain of
amino acids constituting a protein) that emerges from the ribosome is not
yet a functional protein, as it will need to fold into its 3-dimensional struc-
ture. In most organisms, proper protein folding is assisted by proteins called
chaperones that stabilize the unfolded or partially folded proteins, prevent-
ing incorrect folding, as well as chaperonins that directly facilitate folding.
Misfolded proteins are detected and either refolded or degraded. Proteins
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also undergo a variety of PTMs, such as phosphorilation, ubiquitination,
methylation, acetylation, glycosylation, etc., which are additions/removals
of specific chemical groups. PTMs can alter the function and activity level
of a protein and play important roles in cellular regulation and response to
disease or cellular damage.
A key challenge of proteomics is the high complexity of the proteome due
to the one-to-many relationship between genes and proteins and the wide
variety of PTMs. Furthermore, MS-based proteomics does not have the ben-
efit of probe-directed assays like those used in microarrays. Although protein
arrays are available, they (a) are challenging to design and implement and
(b) are not well suited for protein discovery, and are thus not as widely used
as MS-based technologies [Nesvizhskii, Vitek and Aebersold (2007)]. Several
steps are involved in preparing samples for MS, such as protein extraction,
fractionation, digestion, separation and ionization, and each contributes to
the overall variation observed in proteomics data. In addition, technical fac-
tors like day-to-day and run-to-run variation in the complex experimental
equipment can create systematic biases in the data-acquisition stage.
3. Experimental procedure. A LC-MS-based proteomic experiment re-
quires several steps of sample preparation (Figure 2), including cell lysis
to break cells apart, protein separation to spread out the collection of pro-
teins into more homogenous groups, and protein digestion to break intact
proteins into more manageable peptide components. Once this is complete,
peptides are further separated, then ionized and introduced into the mass
spectrometer.
3.1. Sample preparation. Analysis of the complete cell proteome usually
involves collecting intact cells, washing them and adding a lysate buffer,
containing a combination of chemicals that break the cell membrane and
protease inhibitors that prevent protein degradation. Cells are homogenized
and incubated with the buffer, after which centrifugation is used to separate
the cellular debris and membrane from the supernatant, or cell lysate. The
cell lysis step is unnecessary when analyzing bodily fluids such as blood
serum. Blood samples are centrifuged, after which red blood cells pellet at
the bottom of the tube, and plasma is collected at the top. Fibrinogen and
other clotting factors are removed to obtain serum. High abundance proteins
are also removed, as usually they do not play a role in disease. If some of
the high abundance proteins are not removed, they may dominate spectral
features and obscure less abundant proteins of interest. In LC-MS/MS, for
example, the most abundant peptides are selected in the first MS step for
further fragmentation in the following MS step, and only peptides selected
for further fragmentation have a chance to be identified; see Section 3.2 for
more details.
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Because of the complexity of the proteome, separation steps are employed
to spread out the proteins according to different chemical or physical char-
acteristics, making it easier to observe a greater number of proteins in more
detail. At the protein level, two-dimensional gel electrophoresis (2-DE) is
often used to separate on the basis of both isoelectric point and mass [Berth
et al. (2007); Gorg, Weiss and Dunn (2004)]. Proteins in the gel can be
stained and extracted. Analyzing each stained region of the gel separately,
for example, would allow for more detailed assessment of the total collection
of proteins in the sample than if all proteins were analyzed at once. One of
the main sources of error in the gel analysis is unequal precipitation of the
proteins between gels. Thus, horizontal or vertical shifts and even diagonal
stretching effects can be seen in two-dimensional (2-D) gels, necessitating
alignment of all the gels to a reference gel. After gel alignment, spot de-
tection is performed which may introduce further errors; see Section 7.2 for
more details.
To facilitate protein identification, proteins are usually cleaved/digested
chemically or enzymatically into fragments. Digestion overcomes many of
the challenges associated with the complex structural characteristics of pro-
teins, as the resulting peptide fragments are more tractable chemically, and
their reduced size, compared to proteins, makes them more amenable to
MS analysis. As examples of digestion agents, the trypsin enzyme cleaves
at the carboxyl side of lysine and arginine residues, except when either is
followed by proline, while chemical cyanogen bromide (CNBr) cleaves at the
carboxyl site of methionine residues; trypsin is the most commonly used di-
gestive enzyme. Specificity of the trypsin enzyme allows for the prediction
of peptide fragments expected to be produced by the enzyme and create
theoretical databases. Enzymatic digestion of proteins could be achieved in
solution or gel, although digestion in solution is usually preferred, as gel is
harder to separate from the sample after digestion. Missed cleavages can
cause misidentified or missed peptides when searched against the database.
Database searches can be adjusted to include one or more missed cleavages,
but such searches take longer to complete.
Multiple distinct peptides can have very similar or identical molecular
masses and thus produce a single intense peak in the initial MS (MS1) spec-
trum, making it difficult to identify the overlapping peptides. The use of
separation techniques not only increases the overall dynamic range of mea-
surements (i.e., the range of relative peptide abundances) but also greatly re-
duces the cases of coincident peptide masses simultaneously introduced into
the mass spectrometer. We will describe one of the most commonly used sep-
aration techniques, high-performance liquid chromatography (HPLC), which
is generally practiced in a capillary column format for proteomics. Other sep-
aration techniques exist and are similar in that they separate based on some
molecular properties.
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A HPLC system consists of a column packed with nonpolar (hydrophobic)
beads, referred to as the stationary phase, a pump that creates pressure and
moves the polar mobile phase through the column and a detector that cap-
tures the retention time. The sample is diluted in the aqueous solution and
added to the mobile phase. As the peptides are pushed through the column,
they bind to the beads proportionally to their hydrophobic segments. Thus,
hydrophilic peptides will elute faster than hydrophobic peptides. HPLC sep-
aration allows for the introduction of only a small subset of peptides eluting
from the LC column at a particular time into the mass spectrometer. Pep-
tides of similar molecular mass but different hydrophobicity elute from the
LC column and enter the mass spectrometer at different times, no longer
overlapping in the initial MS analysis. The additional time required for the
LC separation is well worth the effort, as the reduction in the overlap of the
peptides of the same mass in MS1 phase dramatically increases peak reso-
lution (and hence, peak capacity). Note that LC columns must be regularly
replaced, and it is common to observe systematic differences in the elution
times of similar samples on difference columns. Thus, replacing a column
during an experiment may contribute to technical variation in the resulting
observed abundances between two columns.
Further separation techniques include sample fractionation prior to HPLC,
and complementary techniques such as Ion Mobility Separation (IMS) after
HPLC. Multidimensional LC has been successfully used to better separate
peptides. Strong cation exchange (SCX) chromatography is usually used
as a first separation step and reversed-phase chromatography (RPLC) as a
secondary separation step because of its ability to remove salts and its com-
patibility with MS through electrospray ionization (ESI, described below)
[Lee et al. (2006); Link et al. (1999); Peng et al. (2003); Sandra et al. (2009);
Sandra et al. (2008)]. Combination of SCX with RPLC forms the basis of
the Multidimensional Protein Identification Technology (MudPIT) approach
[Washburn, Wolters and Yates (2001); Wolters, Washburn and Yates (2001)].
While multidimensional LC is capable of achieving greater separation, it re-
quires larger sample quantities and more analysis time. In HPLC coupled
with IMS, peptides eluting from the HPLC system are ionized using ESI, and
the ions are injected into a drift tube containing neutral gas at controlled
pressure. An electric field is applied, and the ions separate by colliding with
the gas molecules. Larger ions experience more collisions with the gas and
take longer to travel through the drift tube than smaller ions. IMS is very
fast as compared with HPLC and, when used in conjunction with HPLC,
achieves better separation than HPLC alone. IMS is not entirely orthogonal
to HPLC, but it has been shown to increase the peak capacity (number of
detected peaks) by an order of magnitude [Belov et al. (2007)]. While not
currently in wide use, IMS technologies are rapidly evolving, and MS-based
proteomics will likely involve multiple dimensions of separation based on
12 Y. V. KARPIEVITCH ET AL.
both IMS and HPLC in the near future. New algorithms will need to be
developed and existing ones modified to incorporate the extra separation
dimensions.
3.2. Mass spectrometry. A mass spectrometer measures the mass-to-
charge ratio (m/z ) of ionized molecules. Recent years have seen a tremendous
improvement in MS technology, and there are about 20 different mass spec-
trometers commercially available for proteomics. All mass spectrometers are
designed to carry out the distinct functions of ionization and mass analysis.
The key components of a mass spectrometer are the ion source, mass ana-
lyzer and ion detector (Figure 3). The ion source is responsible for assigning
charge to each peptide. Mass analyzers take many different forms but ulti-
mately measure the mass-to-charge (m/z ) ratio of each ion. The detector
captures the ions and measures the intensity of each ion species. In terms
of a mass spectrum, the mass analyzer is responsible for the m/z informa-
tion on the x -axis, and the detector is responsible for the peak intensity
information on the y-axis.
Ionization methods include electron impact, chemical ionization, fast atom
bombardment, field desorption, electrospray ionization (ESI) and laser des-
orption, and they usually operate by the addition of protons to the peptides.
ESI and matrix assisted laser desorption/ionization (MALDI) are the most
widely used methods in proteomics. In the ESI method, the sample is pre-
pared in liquid form at atmospheric pressure and flows into a very fine needle
that is subjected to a high voltage. Due to the electrostatic repulsion, the
solvent drops leaving the needle tip dissociate to form a fine spray of highly
charged droplets. As the solvent evaporates, the droplets disappear, leaving
highly charged molecules. ESI is the most effective interface for LC-MS, as
it naturally accommodates peptides in liquid solution. ESI is a soft ioniza-
tion method, in that it achieves ionization without breaking chemical bonds
and further fragmenting the peptides. In MALDI analysis, the biological
molecules are dispersed in a crystalline matrix. A UV laser pulse is then
directed at the matrix, which causes the ionized molecules to eject so that
they can be extracted into a mass spectrometer.
The mass analyzer is key to the sensitivity, resolution and mass accu-
racy of an instrument. Sensitivity describes an instrument’s ability to detect
low-abundance peptides, resolution to its ability to distinguish ions of very
similar m/z values, and mass accuracy to its ability to obtain mass mea-
surements that are very close to the truth. There are several basic mass
analyzer types: quadrupole (Q), ion-trap (IT), time-of-flight (TOF), Fourier
transform ion cyclotron resonance (FTICR), and the orbitrap. Different an-
alyzers are commonly combined to achieve the best utilization as a single
mass spectrometer (e.g., Q-TOF, triple-Q). We do not go into the details of
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the different mass analyzer types; interested readers are pointed elsewhere
[Domon and Aebersold (2006); Siuzdak (2003)].
In tandem MS (referred to as MS/MS or MSn), multiple rounds of MS
are carried out on the same sample. This results in detailed signatures for
detected features, which can be used for identification. Most MS/MS instru-
ments can automatically select several of the most intense (high abundance)
peaks from a parent MS (MS1) scan and subjects the corresponding ions
(precursor or parent ions) for each to further fragmentation, followed by
further scans. This process is repeated until all candidate peaks of a par-
ent scan are exhausted [Domon and Aebersold (2006); Zhang et al. (2005)].
This results in a fragmentation pattern for each selected peptide, provid-
ing detailed information on the chemical makeup of the peptide. While the
resulting fragmentation patterns are the basis for identification, MS/MS suf-
fers from undersampling, in that relatively few (and generally only higher
intensity) precursor ions are selected for fragmentation [Domon and Aeber-
sold (2006); Garza and Moini (2006); Zhang et al. (2005)]. The issue of
undersampling is not serious enough to steer away from using MSn for pro-
tein identification and quantitation, but researchers should remember that
not all peptides will have equal chances of being selected for fragmentation
and thus may not be observed in the subsequent MS scans. Furthermore,
MS/MS is time-intensive and thus not always ideal for high-throughput
analysis [Masselon et al. (2008)]. Nevertheless, MS/MS is widely used for
quantitative MS-based proteomics and forms the basis for most peptide and
protein identification procedures (Section 5). Typically, MS/MS is preceded
by LC separation and can more accurately be denoted by LC-MS/MS.
High-resolution LC-MS instruments (e.g., FTICR) are very fast and can
achieve mass measurements that are sufficiently accurate for identification
purposes. Furthermore, since fragmentation and repeated scans are not re-
quired, the undersampling issues due to peptide selection for MS/MS are
avoided. Still, fragmentation patterns are valuable for identification, and so
hybrid platforms involving both LC-MS/MS and high-resolution LC-MS are
increasingly being used. One such example is the Accurate Mass and Time
(AMT) tag approach [Pasa-Tolic et al. (2004); Tolmachev et al. (2008);
Yanofsky et al. (2008)]. In the AMT tag approach, MS/MS analysis is used
to create an AMT database of peptide theoretical mass and predicted elu-
tion time, based on high-confidence identifications from fragmentation pat-
terns, followed by a single MS run on FTICR to obtain highly accurate mass
measurements, as well as liquid chromatography elution times; peptide iden-
tification is then made by comparing the observed mass measurements and
elution times to the AMT database entries. We note that an AMT database
is typically constructed using many LC-MS/MS runs, resulting in a nearly
complete database of proteotypic peptides [Mallick et al. (2007)]. Because
in the AMT-based approach LC-MS spectra are matched to the database
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built from previous multiple MS/MS scans, the undersampling associated
with LC-MS/MS on individual samples is avoided.
4. Data acquisition. In LC-MS, each sample may give rise to thousands
of scans, each containing a mass spectrum [Figure 4(a)]. The mass spectrum
for a single MS scan can be summarized by a plot of m/z values versus peak
intensities [Figure 4(b)]. Buried in these data are signals that are specific
to individual peptides. As a first step toward identifying and quantifying
those peptides, features need to be identified in the data and, for example,
distinguished from background noise. The first step in this is MS peak detec-
tion. Many approaches to peak detection have been proposed, as this is an
old problem in the field of signal processing. Our lab employs a simple filter
on the signal-to-noise ratio of a peak relative to its local background [Jaitly
et al. (2009)]. Each peptide gives an envelope of peaks due to a peptide’s con-
stituent amino acids. The presence of a peptide can be characterized by the
m/z value corresponding to the peak arising from the most common isotope,
referred to as the monoisotopic mass. While there are several isotopes of the
elements that make up amino acids, 13C is the most abundant, constituting
about 1.11% of all carbon species. Since the mass difference between 13C
and 12C is approximately 1 Da, the monoisotopic peak for a peptide will be
separated from an isotope with a single 13C by approximately 1/z, where z
is the charge state of that peptide. Similarly, isotopes with additional copies
of 13C will be separated in units of approximately 1/z. [Figure 4(d)].
The process of deisotoping a spectrum is often used to simplify the data
by removing the redundant information from isotopic peaks and involves (i)
locating isotopic distributions in a MS scan, (ii) computing the charge state
of each peptide based on the distance between the peaks in its isotopic dis-
tribution, and (iii) extracting each peptide’s monoisotopic mass. Note that
this step is only possible if sufficiently high-resolution mass measurements
have been obtained, as otherwise isotopic peaks can not be resolved. For
(i), detected peaks are considered as possible members of an isotopic dis-
tribution, and theoretical isotopic distributions, derived from a database of
peptide sequences, are overlaid with the observed spectra. A measure of fit is
computed, and the peaks are called an isotopic distribution if the fit is good
enough. One of the challenges encountered in deisotoping is the presence of
overlapping isotopic distributions from different peptides. There are many
algorithms available for peak detection and deisotoping, including commer-
cial software from vendors such as Agilent, Rosetta Biosoftware and Thermo
Fisher. Our lab uses Decon2LS [Jaitly et al. (2009)], open-source software
that implements a variation of the THRASH algorithm [Horn, Zubarev and
McLafferty (2000)]; the Decon2LS publication contains an extensive discus-
sion of the above issues, as well as many helpful references for the interested
reader.
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A peptide will likely elute from the HPLC over multiple scans, creating
an elution profile [Figure 4(e)]. Elution profiles for peptides are typically
relatively short in duration, and serve to define a feature in LC-MS data
sets. However, there are often contaminants present in an LC-MS sample
with very long elution profiles, and these are filtered out in preprocessing
steps. Various approaches to summarizing an elution profile are available.
Our lab computes a normalized elution time (NET) [Petritis et al. (2006)]. At
this stage, an LC-MS sample has been resolved into a list of LC-MS features,
each with an assigned monoisotopic mass and an elution time. However, due
to mass measurement errors and the random nature of elution times, (mass,
elution time) assigned pairs will vary between LC-MS samples. Alignment is
often performed to line up the LC-MS features in different samples. There are
several algorithms for LC-MS alignment; examples include Crawdad [Finney
et al. (2008)] and LCMSWarp [Jaitly et al. (2006)].
As with all high-throughput -omics technologies, MS-based proteomic
data is typically subjected to substantial preprocessing and normalization.
Systematic biases are often seen in mass measurements, elution times and
peak intensities [Callister et al. (2006); Petyuk et al. (2008)]. Filtering of
poor-quality proteins and peptides is also common [Karpievitch et al. (2009a)].
In normalization, care must be taken to separate biological signal from
technical bias [Dabney and Storey (2006)]. Widely-used normalization tech-
niques in high-throughput genomic or proteomic studies involve some vari-
ation of global scaling, scatterplot smoothing or ANOVA [Quackenbush
(2002)]. Global scaling generally involves shifting all the measurements for
a single sample by a constant amount, so that the means, medians or total
ion currents (TICs) of all samples are equivalent. Since common technical
biases are more complex than simple shifts between samples, global scaling
is unable to capture complex bias features. Scatterplot smoothing, TIC and
ANOVA normalization methods are sample-specific and hence more flexi-
ble. However, more complex preprocessing steps can result in overfitting,
causing errors in downstream inference. For example, fitting a complex pre-
processing model may use up substantial degrees of freedom, and analyzing
the processed data, assuming that no degrees of freedom have been used,
may result in overly optimistic accuracy levels and overestimated statistical
significance; specific examples can be seen in Karpievitch et al. (2009b). Ide-
ally, preprocessing would be carried out simultaneously with inference, or
the downstream inferential steps would incorporate knowledge of what pre-
processing was done [Leek and Storey (2007)]. A recently proposed method,
called EigenMS, removes bias of arbitrary complexity by the use of the sin-
gular value decomposition to capture and remove biases from LC-MS peak
intensity measurements [Karpievitch et al. (2009b)]. EigenMS removes bi-
ases of arbitrary complexity and adjusts the normalized intensities to correct
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the p-values after normalization (ensuring that null p-values are uniformly
distributed).
Mass spectrometer manufacturers have developed a variety of propri-
etary binary data formats to store instrument output. Examples include
.baf (Bruker), .Raw (Thermo) and .PKM (Applied Biosystems). Handling
data in different proprietary formats typically requires corresponding pro-
prietary software, making it difficult to share datasets. Several open-source,
XML-based vendor-independent data formats have recently been developed
to address this limitation: mzXML [Lin et al. (2005); Pedrioli et al. (2004)],
mzData [Orchard et al. (2007)] and mzML [Deutsch (2008); Orchard et al.
(2009)]. mzML 1.0 was released in June 2009 and is considered a merge
of the best of mzData and mzXML. The format can store spectral infor-
mation, instrument information, instrument settings and data processing
details. mzML also has extensions such as chromatograms and multiple re-
action monitoring (MRM) profile capture, and it now replaces both mzData
and mzXML.
5. Protein identification. In bottom-up proteomics protein identifica-
tion is usually accomplished by first comparing observed MS features to
a database of predicted or previously identified features (e.g., by MS/MS
or on the basis of previous analysis of a well characterized sample, Figure
5). The most widely-used approach is tandem MS with database search-
ing [Nesvizhskii, Vitek and Aebersold (2007)], in which peptide fragmenta-
tion patterns are compared to theoretical patterns in a database using soft-
ware like Sequest [Eng, McCormack and Yates (1994)], X!Tandem [Craig
and Beavis (2004)] and Mascot [Perkins et al. (1999)]. With high-resolution
LC-MS instruments, identifications can be made on the basis of mass and
elution time alone, or in conjunction with MS/MS fragmentation patterns
[Pasa-Tolic et al. (2004)]. Alternatives to database-searching include (i) de
novo peptide sequencing [Dancik et al. (1999); Johnson et al. (2005); Lu
and Chen (2003); Standing (2003)] and (ii) hybrids of the de novo and
database searching approaches [Frank and Pevzner (2005); Sunyaev et al.
(2003); Tabb, Saraf and Yates (2003); Tanner et al. (2005)]. For detailed
reviews of the database searching algorithms see Kapp and Schutz (2007),
Nesvizhskii (2007), Nesvizhskii, Vitek and Aebersold (2007), Sadygov, Co-
ciorva and Yates (2004) and Yates (1998).
In tandem MS, precursor ions for the most abundant peaks in a scan are
fragmented and scanned again. In collision-induced dissociation (CID), pre-
cursor ions are fragmented by collision with a neutral gas [Laskin and Futrell
(2003); Pittenauer and Allmaier (2009); Sleno and Volmer (2004); Wells and
McLuckey (2005)]. Subsequent MS analysis measures the m/z and intensity
of the fragment ions (product or daughter ions), creating a fragmentation
pattern (Figure 5). CID usually leads to b- and y-ions through breakage of
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the amide bond along the peptide backbone. b-ions are formed when the
charge is retained by the amino-terminal fragment, and y-ions are formed
when charge is retained by the carboxy-terminal fragment. Breaks near the
amino acids glutamic acid (E), aspartic acid (D) and proline (P) are more
common, as well as breaking of the side-chains [Sobott et al. (2009)]. Other
fragmentation patterns are possible, such as a-, c-, x - and z -types. Electron
capture dissociation (ECD) produces c- and z -ions and leaves side-chains
intact. The fragmentation pattern is like a fingerprint for a peptide. It is
a function of amino acid sequence and can therefore be predicted. The ob-
served fragmentation pattern should match well with its theoretical pattern,
assuming that its peptide sequence is included in the search database.
A search database is created by specifying a list of proteins expected to
contain any proteins present in a sample. In human studies, for example,
the complete known proteome can be specified with a FASTA file, which
can then be used to create peptide fragment sequences by simulating diges-
tion with trypsin. For each resulting peptide, a theoretical fragmentation
pattern is then created. For details on protein digestion and fragmentation
see Siuzdak (2003). Several software programs are available for database
matching (e.g., SEQUEST, X!Tandem and Mascot). Each has its own al-
gorithm for assessing the fit between observed and theoretical spectra, and
there can be surprisingly little overlap in their results [Searle, Turner and
Nesvizhskii (2008)]. Note that a correct match can only be made if the cor-
rect sequence is in the database in the first place. If an organism’s genome is
incomplete or has errors, this will not be the case. Furthermore, because of
undersampling issues in MS/MS, only a small percentage of peptides present
in a sample will even be considered for identification. This is due to the fact
that only a small portion of higher abundance peaks (for example, the 10
most abundant peaks) are selected from the spectra in the first MS step for
fragmentation in the second MS analysis. Thus, lower abundance proteins
are obscured by the presence of the high abundance ones.
High-resolution LC-MS instruments can be used to identify peptides on
the basis of extremely accurate mass measurements and LC elution times.
A database is again required, containing theoretical or previously-observed
mass and elution time measurements. In hybrid approaches, like the AMT
tag approach [Pasa-Tolic et al. (2004)], identifications from MS/MS are used
to create a database of putative mass and time tags for comparison with
high-resolution LC-MS data. Since MS/MS is sample- and time-intensive,
hybrid approaches allow for higher-throughput analysis, subjecting only a
subset of the sample to MS/MS and the rest to rapid LC-MS. Alternatively,
previously-observed MS/MS fragmentation patterns can be used to create a
mass and time tag database. By using many LC-MS/MS datasets in the cre-
ation of the database, the undersampling issues associated with LC-MS/MS
are avoided.
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In each of the above approaches, there is a statistical problem of assessing
confidence in database matches. This is typically dealt with in one of two
ways. The first involves modeling a collection of database match scores as a
mixture of a correct-match distribution and an incorrect-match distribution.
The confidence of each match is assessed by its estimated posterior proba-
bility of having come from the correct-match distribution, conditional on its
observed score [Ka¨ll et al. (2008b)]; PeptideProphet is a widely-used exam-
ple [Keller et al. (2002)]. Improvements have been made to PeptideProphet
to avoid fixed coefficients in computation of discriminant search score and
utilization of only one top scoring peptide assignment per spectrum [Ding,
Choi and Nesvizhskii (2008)]. Decoy databases are an alternative approach,
in which the search database is scrambled so that any matches to the decoy
database can be assumed to be false [Choi, Ghosh and Nesvizhskii (2008);
Ka¨ll et al. (2008a)]. The distribution of decoy matches is then used as the null
distribution for the observed scores for matches to the search database, and
p-values are computed as simple proportions of decoy matches as strong or
stronger than the observed matches from the search database. A hybrid ap-
proach that combines mixture models with decoy database search can also
be used [Choi and Nesvizhskii (2008b)]. Whether working from posterior
probabilities or p-values, lists of high-confidence peptide identifications can
be selected in terms of false discovery rates [Choi and Nesvizhskii (2008a);
Storey and Tibshirani (2003)]. Both decoy database matching and empirical
Bayes approaches are global, in that they model the distribution of database
match scores for all spectra at the same time. An “expectation value” is an
alternative significance value, which models the distribution of scores for a
single experimental spectrum with all peptide match scores from the theo-
retical database [Fenyo¨ and Beavis (2003)].
An alternative to database search approaches is de novo sequencing [Dan-
cik et al. (1999); Frank and Pevzner (2005); Johnson et al. (2005); Lu and
Chen (2003); Standing (2003); Tabb, Saraf and Yates (2003)]. De novo se-
quencing involves assembling the amino acid sequences of peptides based on
direct inspection of spectral patterns. For a given amino acid sequence, the
possible fragmentation ions and masses can be enumerated, as well as the ex-
pected frequency with which each type of fragment ion would be formed. De
novo sequencing therefore tries to find the sequence for which an observed
spectral pattern is most likely. The key distinction from database-search ap-
proaches is that there is no need for a priori sequence knowledge. Suppose,
for example, that we are studying human samples. With database-search,
we would load a human proteome FASTA file and only have access to amino
acid sequences generated therein. With de novo sequencing, any amino acid
sequence could be considered. This can be important when studying organ-
isms with incomplete or imperfect genome information [Ram et al. (2005)].
MASS SPECTROMETRY-BASED PROTEOMICS 19
Drawbacks include increased computational expense as well as the need for
relatively large sample quantities.
Combinations of de novo sequence tag generation and database searching
(hybrid methods) are widely used in PTM identification [Mann and Wilm
(1994)]. The de novo approach infers a peptide sequence tag (not the full-
length peptide) from the spectrum without searching the protein database.
These sequence tags can then be used to filter the database to reduce its
size, which in turn speeds up the calculation of the spectrum matches with
all possible PTMs. InsPect is a widely used tool for identification of PTMs
[Tanner et al. (2005)]. Lui et al. proposed a similar sequence tag-based ap-
proach with a deterministic finite automaton model for searching a peptide
sequence database [Liu et al. (2006)].
While bottom-up MS-based proteomics deals with peptides, the real goal
is to identify proteins present in a sample. In most cases, a peptide amino
acid sequence can be used to identify the protein from which it was derived.
Software like ProteinProphet can translate peptide-level identifications to
the protein level and assign each resulting protein identification a confidence
measure [Nesvizhskii et al. (2003)]. A key challenge in translating peptide
identifications to the protein level is degeneracy. A degenerate peptide is one
that could have come from multiple proteins; this is most common for pep-
tides with short amino acid sequences or ones that come from homologous
proteins (where homology refers to a similarity in amino acid sequences).
Based on the information present in an individual degenerate peptide, it is
not necessarily clear how to decide between multiple proteins. However, by
taking the information present in uniquely identified and degenerate pep-
tides that were identified as belonging to multiple proteins into account,
sensible model-based decisions can be achieved [Shen et al. (2008)]. Pep-
tideProphet shares degenerate peptides among their corresponding proteins
and produces a minimal protein list that accounts for such peptides. Another
challenge is due to the fact that correctly identified peptides usually belong
to a small set of proteins, but incorrectly identified peptides match randomly
to a large variety of proteins. Thus, a small number of incorrectly identified
peptides (with high scores) can make it difficult to determine the correct
parent protein, especially in a single-peptide identification, and may result
in a much higher error rate at the protein level [Nesvizhskii and Aebersold
(2004)].
6. Protein quantitation. Quantitative proteomics is concerned with quan-
tifying and comparing protein abundances in different conditions (Figure
6). There are two main approaches: stable isotope labeling and label free.
In all cases, as in the identification setting, there is the challenge of rolling
peptide-level information up to the protein level. This can be viewed as an
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analogous problem to the probe-set summarization step required with many
DNA microarrays [Li and Wong (2001)].
In label-based quantitative LC-MS, chemical, metabolic or enzymatic sta-
ble isotope labels are incorporated into control and experimental samples,
the samples are mixed together and then analyzed with LC-MS [Goshe and
Smith (2003); Guerrera and Kleiner (2005); Gygi et al. (1999)]. In chemical
labeling, such as isotope-coded affinity tag (ICAT), Cystine (Cys) residues
are labeled [Gygi et al. (1999)]. In metabolic labeling, cells from two different
conditions are grown in media with either normal amino acids (1H/12C/14N)
or stable isotope amino acids (2H/13C/15N) [Oda et al. (1999); Ong et al.
(2002)]. This approach is not applicable to human or most mammalian pro-
tein profiling. In enzymatic labeling, proteins from two groups are digested in
the presence of normal water (H2
16O) or isotopically labeled water (H2
18O)
[Schnolzer, Jedrzejewski and Lehmann (1996); Ye et al. (2009)]. In all of
the above methods, differences in label weight create a shift in m/z values
for the same peptide under the two conditions. After tandem mass analysis
(LC-MS/MS), spectra are matched against a database, and ratios of peptide
abundances in the two conditions are determined by integrating the areas
under the peaks of each labeled ion that was detected. Strong linear agree-
ment has been shown between true concentrations and those estimated by
label-based approaches [Old et al. (2005)]. Of the two quantitation methods
considered here, label-based methods are able to achieve the most precise
estimates of relative abundance. Limitations include the following: (i) its
restriction to two comparison groups, (ii) associated difficulties with in-
corporating future samples into an existing data set, and (iii) expense. A
newer method that allows for the comparison of four treatment samples at a
time and avoids the cystine-selective affinity of ICAT is iTRAQ [Ross et al.
(2004); Thompson et al. (2003); Wiese et al. (2007)]. iTRAQ uses isobaric
labels at N-terminus which have two components: reporter and balance moi-
eties. Combined reporter and balance moieties always have masses of 145
Da. For example, if for treatment group one we use reporter of mass 114 and
balance of mass 31, then for another treatment group we can use reporter of
mass 116 and balance of mass 29. Precursor ions from all treatment groups
appear as a single peak of the same weight in MS1. After further fragmen-
tation, peptides break down into smaller pieces and separate balance and
reporter ions. Reporter ions thus appear as distinct masses, and peptide
abundances are determined from those. iTRAQ is limited to four or eight
group comparisons, but limitations (ii) and (iii) above still apply.
Label-free quantitative analysis measures relative protein abundances with-
out the use of stable isotopic labels. In contrast to label-based methods,
samples from different comparison groups are analyzed separately, allowing
for more complex experiments as well as the addition of subsequent samples
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to an analysis; label-free methods are also faster than label-based meth-
ods. Label-free quantification can be grouped into two categories: spectral
feature analysis and spectral counting. In spectral feature analysis, peak ar-
eas of identified peptides are used for abundance estimates. The peak areas
are sometimes normalized to the peak area of an internal standard protein
spiked into the sample at a known concentration level. Good linear correla-
tion between estimated and true relative abundances has been shown for this
method of peptide quantification [Bondarenko, Chelius and Shaler (2002);
Chelius and Bondarenko (2002); Old et al. (2005); Wang et al. (2003)]. In
spectral counting, peptide abundances for one sample are estimated by the
count of MS/MS fragmentation spectra that were observed for each identi-
fied peptide [Choi, Fermin and Nesvizhskii (2008)]. Repeated identifications
of the same peptide in the same sample are due to its presence in several
proximal scans constituting its elution profile. Good linear correlation be-
tween true and estimated relative abundance from spectral counting have
been shown [Ghaemmaghami et al. (2003); Liu, Sadygov and Yates (2004)].
Spectral counts are easy to collect and do not require peak area integration
like spectral peak analysis or label-based methods.
Missing peptides are common in MS-based proteomic data. In fact, it
is common to have 20–40% of all attempted intensity measures missing.
Abundance measurements are missed if, for example, a peptide was identified
in some samples but not in others. This can happen in several ways: (i)
the peptide is present in low abundances, and in some samples the peak
intensities are not high enough to be detected or for the corresponding ions
to be selected for MS/MS fragmentation, (ii) competition for charge in the
ionization process, by which some ion species are liable to be dominated by
others, and (iii) peptides whose chemical or physical structure cause them to
get trapped in the LC column, among others. Mechanism (i) is essentially a
censoring mechanism and appears to be responsible for the vast majority of
missing values [Figure 6(a)]. This complicates intensity-based quantitation,
as simple solutions will tend to be biased. For example, analysis of only the
observed intensities will tend to overestimate abundances and underestimate
variances. Simple imputation routines like row-means or k -nearest-neighbors
suffer from similar limitations. Statistical models are needed to address these
issues, as well as to handle the peptide-to-protein rollup [Karpievitch et al.
(2009a); Wang et al. (2006); also, see Figure 6(b)]. Note that a further benefit
of spectral counting is that it is less sensitive to missing values.
We note that protein identification and quantitation are complementary
exercises. Unidentified proteins cannot be quantified, and the confidence
with which a protein was identified should perhaps be incorporated into that
protein’s abundance estimate. Degenerate peptides, for example, present
problems for both identification and quantitation, but evidence for the pres-
ence of sibling peptides from one protein in high abundance can be useful
in deciding between multiple possible protein identities.
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7. Other technologies.
7.1. MALDI and mass fingerprinting. MALDI (matrix assisted lazed
desorption ionization) is mostly used for single MS, typically using a TOF
mass analyzer. MALDI refers to the method of ionization, in which a laser
is pulsed at a crystalline matrix containing the sample (analyte) [Guerrera
and Kleiner (2005); Karas et al. (1987)]. The analyte is mixed with the
matrix solution, spotted in a well on a MALDI plate and allowed to crystal-
lize. The matrix consists of small organic molecules that absorb light at the
wavelength of the laser radiation. Upon absorption, the matrix molecules
transfer energy to the sample molecules to permit ionization and desorp-
tion of even large molecules as intact gas-phase ions; the matrix also serves
to protect the analyte from being destroyed by the laser pulse. MALDI is
considered a soft ionization technique, resulting in very little analyte frag-
mentation. Crystallized samples can be stored for some time before analysis
or for repeated analysis.
While MALDI MS/MS instruments exist, MALDI is most commonly used
for mass fingerprinting, where spectral patterns are identified for discrimi-
nating samples from different conditions (e.g., cancer vs. normal). Machine
learning techniques, such as linear discriminant analysis, Random Forest and
Support Vector Machine, among others, are typically used to build classifiers
in hopes of finding tools for the early detection of a disease. Disease biomark-
ers (specific m/z values) can be identified from the set of the differentially
expressed features. However, to date, the success rate for identification of
true biomarkers is low, in part due to the poor reproducibility of the ex-
periments in time and between labs [Baggerly, Morris and Coombes (2004);
Petricoin et al. (2002)].
7.2. 2-D gels. 2-D gel electrophoresis (2-DE) is an alternative technique
for protein separation [Gorg, Weiss and Dunn (2004); Klose and Kobalz
(1995); Weiss and Gorg (2009)], first introduced in 1975 [Klose (1975);
O’Farrell (1975)]. Here, two orthogonal separations are used: proteins are
first separated based on their isoelectric point (pI), then based on their size
(mass). The first dimension utilizes the fact that the net charge of the pro-
tein is pH-dependent. Proteins are loaded into the pH gradient (variable pH)
and subjected to high voltage. Each protein migrates to the pH location in
the gradient where its charge is zero and becomes immobilized there. The
second dimension gel contains SDS, detergent molecules with hydrophobic
tails and negatively charged heads. SDS denatures (unfolds) the proteins and
adds negative charge in proportion to the size of the protein. An electric field
is applied to move negatively charged proteins toward the positively charged
electrode, smaller proteins migrating through the gel faster than larger ones.
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Multiple copies of the proteins will generally move at the same speed and
will end up fixated in bulk at a certain spot on the gel.
Protein detection is performed with staining (most common) or radio-
labeling. Proteins can then be quantified based on their spot intensity. The
staining intensity is approximately a linear function of the amount of protein
present. Images of the 2-D gels can be compared between different compar-
ison groups to study protein variations between the groups and identify
biomarkers. The following steps are generally required before quantitative
and comparative analysis can be done, not necessarily in this order: (a)
denoising, (b) background correction, (c) spot detection, (d) spot match-
ing/gel alignment, (e) spot quantification. Although all steps are needed,
spot matching is the most important, as proteins can shift along the axis
from image to image (gel to gel) as well as exhibit a pattern of stretching
along the diagonals. Examples of programs designed to perform the above
steps are Progenesis (Nonlinear Dynamics Ltd., Newcastle-upon-Tyne, UK)
and PDQuest Version 8.0 (Bio-Rad Laboratories, Hercules, CA, USA), both
of which are proprietary. Pinnacle is an open source program that performs
spot detection and quantification in the aligned gels [Morris, Clark and Gut-
stein (2008)].
8. Discussion. While the field of LC-MS-based proteomics has seen rapid
advancements in recent years, there are still significant challenges in pro-
teomic analysis. The complexity of the proteome and the myriad of compu-
tational tasks that must be carried out to translate samples into data can
lead to poor reproducibility. Advancements in mass spectrometry and sep-
aration technologies will surely help, but there will continue to be a crucial
role for statisticians in the design of experiments and methods specific to
this setting. Careful assessments of the capabilities of current LC-MS-based
proteomics to achieve certain levels of sensitivity and specificity, based on
instrument configuration, experimental protocol, experimental design, sam-
ple size, etc., would be extremely valuable for assisting in the establishment
of best-practices, as well as for gauging the capabilities of the technology;
the National Cancer Institute’s Clinical Proteomic Technologies for Cancer
program is an example. It is likely the case that very large studies will be
required for true breakthrough findings (e.g., biomarkers) in systems biology
using proteomics.
Specific methodological areas that can use additional input from statisti-
cians include the development of statistical models for rolling up from pep-
tides to proteins; determination of protein networks; construction of con-
fidence levels with which we identify peptides and subsequently proteins;
alignment of LC-MS runs and assurance of quality of those alignments, that
is, assigning a p-value to a set of aligned LC-MS runs to assess “correctness”
of alignment. Furthermore, as additional dimensions of separation (as in
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IMS-LC-MS) are introduced, more flexible and generalizable preprocessing,
estimation and inferential methods will be required. In general, statisticians
can play a pivotal role in LC-MS-based proteomics (as well as other -omics
technologies) by participating in interdisciplinary research teams and assist-
ing with the application of classical statistical concepts [Oberg and Vitek
(2009)]. In particular, the statistician can contribute by ensuring that well-
planned experimental designs are employed, assumptions required for reli-
able inference are met, and proper interpretation of statistical estimates and
inferences are used [Dougherty (2009); Hand (2006)]. These contributions are
arguably more valuable than the development of additional algorithms and
computational methods. Due to the great complexity of high-throughput
-omics technologies and the data that result, careful statistical reasoning is
imperative.
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